Fundies. English
Segment disclosures
Company overviewProtalix BioTherapeutics, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
2 dimension combinations 17 retained observations 10 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Single Operating Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=plx:SingleOperatingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 19896000 | Unit_Standard_USD_uvWCv9OaDk2a6gRWcmozQA | 20260812 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 53646000 | Unit_Standard_USD_uvWCv9OaDk2a6gRWcmozQA | 20260812 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 52744000 | Unit_Standard_USD_BlbbkG4VzU6CwONxX6vYIg | 20260318 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 15658000 | Unit_Standard_USD_uvWCv9OaDk2a6gRWcmozQA | 20260812 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 25771000 | Unit_Standard_USD_uvWCv9OaDk2a6gRWcmozQA | 20260812 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 53399000 | Unit_Standard_USD_BlbbkG4VzU6CwONxX6vYIg | 20260318 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 65494000 | Unit_Standard_USD_BlbbkG4VzU6CwONxX6vYIg | 20260318 | Open filing evidence |
Single Reportable Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=plx:SingleReportableSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 33750000 | Unit_Standard_USD_JFe-IxfnIEeomulRJRf3Tw | 20260513 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 17851000 | Unit_Standard_USD__ZnT9pJrnkSKE5wy3-sNyg | 20251113 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 43622000 | Unit_Standard_USD__ZnT9pJrnkSKE5wy3-sNyg | 20251113 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 15658000 | Unit_Standard_USD_z3XlW9HYx0--Nwg6A5i8bA | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 25771000 | Unit_Standard_USD_z3XlW9HYx0--Nwg6A5i8bA | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10113000 | Unit_Standard_USD_JFe-IxfnIEeomulRJRf3Tw | 20260513 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 17959000 | Unit_Standard_USD__ZnT9pJrnkSKE5wy3-sNyg | 20251113 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 35181000 | Unit_Standard_USD__ZnT9pJrnkSKE5wy3-sNyg | 20251113 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 13474000 | Unit_Standard_USD_z3XlW9HYx0--Nwg6A5i8bA | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 17222000 | Unit_Standard_USD_z3XlW9HYx0--Nwg6A5i8bA | 20250814 | Open filing evidence |